Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-14 2:57 pm Purchase | 2025-03-31 | 13G | 60 DEGREES PHARMACEUTICALS INC SXTP | Ayrton Capital LLC | 40,870 9.990% | 40,870 (New Position) | Filing History |
| 2025-05-14 2:55 pm Purchase | 2025-03-31 | 13G | GREENLANE HLDGS INC PAR V GNLN | Ayrton Capital LLC | 142 9.990% | 142 (New Position) | Filing History |
| 2025-05-14 2:52 pm Purchase | 2025-03-31 | 13G | AZITRA INC AZTR | Ayrton Capital LLC | 11,072,416 9.990% | 11,072,416 (New Position) | Filing History |
| 2025-02-13 1:50 pm Purchase | 2024-12-31 | 13G | IMUNON, INC. IMNN | Ayrton Capital LLC | 83,333 7.900% | 13,037 (+18.55%) | Filing History |
| 2025-02-13 1:47 pm Sale | 2024-12-31 | 13G | TRIO PETE CORP COM TPET | Ayrton Capital LLC | 4,277 0.100% | -22,209 (-83.85%) | Filing History |
| 2025-02-13 1:46 pm Sale | 2024-12-31 | 13G | TOUGHBUILT INDS INC PAR $. TBLT | Ayrton Capital LLC | 65,812 4.400% | -4,031,322 (-98.39%) | Filing History |
| 2025-02-13 1:44 pm Sale | 2024-12-31 | 13G | PETROS PHARMACEUTICALS INC PTPI | Ayrton Capital LLC | 26,305 6.200% | -611 (-2.27%) | Filing History |
| 2025-02-13 1:42 pm Sale | 2024-12-31 | 13G | PHARMACYTE BIOTECH INC PMCB | Ayrton Capital LLC | 774,100 9.900% | -182,129 (-19.05%) | Filing History |
| 2025-02-13 1:40 pm Purchase | 2024-12-31 | 13G | PAVMED INC PAVM | Ayrton Capital LLC | 40,877 9.900% | 12,510 (+44.10%) | Filing History |
| 2025-02-13 1:38 pm Sale | 2024-12-31 | 13G | LUCID DIAGNOSTICS INC LUCD | Ayrton Capital LLC | 1,200,485 2.000% | -3,755,213 (-75.78%) | Filing History |
| 2025-02-13 1:35 pm Sale | 2024-12-31 | 13G | KWESST MICRO SYS INC KWE | Ayrton Capital LLC | 5,643 7.000% | -50,786 (-90.00%) | Filing History |
| 2025-02-13 1:33 pm Unchanged | 2024-12-31 | 13G | SEASTAR MED HLDG CORP COM ICU | Ayrton Capital LLC | 29,436 6.200% | 0 (Unchanged) | Filing History |
| 2025-02-13 1:32 pm Unchanged | 2024-12-31 | 13G | GENIUS GROUP LTD SHS GNS | Ayrton Capital LLC | 1,953,162 8.300% | 0 (Unchanged) | Filing History |
| 2025-02-13 1:23 pm Sale | 2024-12-31 | 13G | ARCIMOTO INC FUVV | Ayrton Capital LLC | 945,930 9.900% | -4,571 (-0.48%) | Filing History |
| 2025-02-13 1:20 pm Unchanged | 2024-12-31 | 13G | CHINA NAT RES INC SHS COM CHNR | Ayrton Capital LLC | 69,744 5.400% | 0 (Unchanged) | Filing History |
| 2025-02-13 1:17 pm Purchase | 2024-12-31 | 13G | ADDENTAX GROUP CORP COM PAR $0 ATXG | Ayrton Capital LLC | 43,103 9.900% | 14,343 (+49.87%) | Filing History |
| 2025-02-13 1:14 pm Purchase | 2024-12-31 | 13G | TRITIUM DCFC LTD DCFC | Ayrton Capital LLC | 18,777,000 9.900% | 18,685,060 (+20323.10%) | Filing History |
| 2025-02-13 1:11 pm Purchase | 2024-12-31 | 13G | OCEAN BIOMEDICAL INC OCEA | Ayrton Capital LLC | 3,873,632 9.900% | 91,866 (+2.43%) | Filing History |
| 2025-02-13 1:07 pm Purchase | 2024-12-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Ayrton Capital LLC | 403,650 9.900% | 403,650 (New Position) | Filing History |
| 2025-02-13 1:05 pm Purchase | 2024-12-31 | 13G | GLIMPSE GROUP INC GGRP | Ayrton Capital LLC | 1,860,380 9.900% | 1,860,380 (New Position) | Filing History |